Wednesday - April 30, 2025

LOGIN  |  REGISTER
Amneal Pharmaceuticals

Over 2,400 Surgical Cases Completed Using Stryker’s Q Guidance System with Spine Guidance Software in First Year

October 12, 2023 | Last Trade: US$373.92 3.00 0.81
  • Stryker to showcase Q Guidance System with spine and cranial applications at NASS Annual Meeting

LEESBURG, Va. / Oct 12, 2023 / Business Wire / Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today that its Q Guidance System with Spine Guidance Software has been used to deliver enhanced surgical planning and navigation in over 2,400 spinal cases. The Q Guidance System for both spine and cranial applications will be featured at the North American Spine Society (NASS) annual meeting in Los Angeles, Oct. 18 - 21, booth no. 1701.

“The surgeon feedback on our Q Guidance System with Spine Guidance Software is overwhelmingly positive, and the number of completed surgical cases has exceeded our expectations,” said Keith Evans, vice president and general manager of Stryker’s Enabling Technologies business. "We’ve seen firsthand how it has helped surgeons optimize their workflow and time spent in the OR. It’s also exciting that we could expand our reach by making this technology available for use with pediatric patients aged 13 and older. The Q Guidance System continues our legacy of ingenuity and is currently the center of our enabling technologies ecosystem that we continue to build upon year over year.”

The Q Guidance System with Spine Guidance Software, which launched in 2022, delivers unmatched speed and the flexibility of multiple optical tracking methods, including full-spectrum active/passive hybrid optical tracking, semi-automatic and automatic processing features, gesture recognition, and broad compatibility with various types of image sets.1

"As a diehard freehand pedicle screw inserter, my first case with the Q Guidance System with Spine Guidance Software changed my views on navigation,” said Dr. Peter Newton*, chief of the Division of Orthopedics & Scoliosis and surgeon-in-chief at Rady Children’s Hospital in San Diego, California. “In surgeries like these, I believe perfect screw positioning and maximal screw length are critical, and both were achieved for this patient. The ability to move the tracker and re-register quickly without another CT scan is a spectacular advance in navigation."

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually.

More information is available at www.strykeronegiantleap.com.

References:

  1. Stryker data on file.

* Dr. Peter Newton is a paid consultant of Stryker. His statements represent his own opinions based on personal experience and are not necessarily those of Stryker. Individual results may vary.

Stock Quote

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page